Novavax and Serum Institute announced submission to WHO for Emergency Use Listing of COVID-19 vaccine
On Sept. 23, 2021, Novavax with its partner, Serum Institute of India announced a regulatory submission to the…
On Sept. 23, 2021, Novavax with its partner, Serum Institute of India announced a regulatory submission to the…
On Sept. 23, 2021, Pfizer and BioNTech announced that the U.S. Food and Drug Administration (FDA) has authorized…
On Sept. 23, 2021, Tonix Pharmaceuticals announced it had expanded its research collaboration with Columbia University. The research…
On Sept. 23, 2021, OraSure Technologies and the Biomedical Advanced Research Development Authority (BARDA) announced up to $13.6…
On Sept. 22, 2021, the Breakthrough Prize Foundation and its founding sponsors announced the 2022 winners of the…
On Sept. 22, 2021, Dynavax Technologies announced that Clover Biopharmaceuticals reported positive data for their protein-based COVID-19 vaccine…
On Sept. 22, 2021, Gilead Sciences announced positive results from a Phase 3 randomized, double-blind, placebo-controlled trial to…
On Sept. 22, 2021, Pfizer and BioNTech announced plans to expand their agreement with the U.S. government by…
On Sept. 22, 2021, Inovio Pharmaceuticals announced that it had received authorization from COFEPRIS, the national health regulatory…
On Sept. 20, 2021, Eiger BioPharmaceuticals announced announced that Peginterferon Lambda (Lambda) will be added to the ongoing,…
On Sept. 20, 2021, Pfizer and BioNTech announced results from a Phase 2/3 trial showing a favorable safety…
On Sept. 20, 2021, the University of Oxford and Oracle’s Global Pathogen Analysis System announced that it was…
On Sept. 17, 2021, the lions and tigers at the Smithsonian’s National Zoo were reported testing presumptive positive…
On Sept. 17, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 17, 2021, the Centers for Disease Control and Prevention (CDC) announced a $2.1 billion investment to…
On Sept. 17, 2021, Oxfordï¾’s Leverhulme Centre for Demographic Science reported the COVID-19 pandemic triggered life expectancy losses…
On Sept. 16, 2021, the WHO reported that the continent faced almost 500 million doses short of the…
On Sept. 16, 2021, Moderna announced Health Canada had approved the New Drug Submission (NDS-CV) for SPIKEVAX (elasomeran…
On Sept. 16, 2021, Novavax announced its participation in a newly expanded Phase 2 clinical trial called Comparing…
On Sept. 16, 2021, Celsion and Hainan Poly Pharm announced an amendment to their existing contract manufacturing agreement…
On Sept. 15, 2021, the National Institutes of Health (NIH) awarded nearly $470 million to build a national…
On Sept. 15, 2021, Oragenics announced the initiation of a study to evaluate the immunogenicity and viral load…
On Sept. 15, 2021, Moderna announced new analysis suggesting that the COVID-19 vaccine was highly effective against circulating…
On Sept. 15, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…
On Sept. 15, 2021, InBios announced that it had received Emergency Use Authorization from the U.S. Food and…
On Sept. 14, 2021, the NIH announced that an international project called the COVID Human Genetic Effort has…
On Sept. 14, 2021, Emergent BioSolutions announced a five-year contract development and manufacturing (CDMO) services agreement spanning Emergentï¾’s…
On Sept. 14, 2021, City of Hope announced that it had begun enrolling patients in a Phase 2…
On Sept. 10, 2021, Zoo Atlanta reported that it had received presumptive positive test results indicating that members…
On Sept. 10, 2021, the U.S. Department of Defense in coordination with the Department of Health and Human…